MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on November 30, 2007; DOI: 10.1124/mol.107.039008


This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.107.039008v1
73/3/880    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baenziger, J. E.
Right arrow Articles by daCosta, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baenziger, J. E.
Right arrow Articles by daCosta, C. J.


Received for publication June 18, 2007.
Revised November 29, 2007.
Accepted for publication November 30, 2007.

Lipid composition alters drug action at the nicotinic acetylcholine receptor

John E. Baenziger 1*, Stephen E Ryan 1, Michael M Goodried 1, Ngoc Q Vuong 1, Raymond M Sturgeon 1, Corrie JB daCosta 1

1 University of Ottawa

* Address correspondence to: E-mail: jebaenz{at}uottawa.ca

Abstract

We tested the hypothesis that membrane lipid composition influences drug action at membrane proteins by studying local anesthetic action at the nicotinic acetylcholine receptor (nAChR). Infrared difference spectra show that concentrations of tetracaine consistent with binding to the ion channel (<50 µM) stabilize a resting-like state when the nAChR is reconstituted into phosphatidylcholine membranes containing the anionic lipid, phosphatidic acid, but have no effect on the nAChR reconstituted into membranes lacking phosphatidic acid, either in the presence or absence of cholesterol. Concentrations of tetracaine above 200 µM lead to neurotransmitter site binding in all membranes. In the presence of phosphatidic acid and/or cholesterol, neurotransmitter site binding leads to the formation of quaternary amine-aromatic interactions between tetracaine and binding site tyrosine/tryptophan residues and the stabilization of a desensitized state. One interpretation suggested by lipid partitioning studies is that phosphatidic acid enhances tetracaine action at the channel pore by increasing the partitioning of tetracaine into the lipid bilayer and thus enhancing access to the transmembrane pore. Subtle membrane-dependent variations in the vibrations of tyrosine and tryptophan residues, as well as agonist analog binding studies, however, indicate that the structures of the agonist-bound neurotransmitter sites of the nAChR in membranes lacking both phosphatidic acid and cholesterol differ from the structures of the agonist-desensitized neurotransmitter sites in the presence of both lipids. Lipid action at the nAChR thus involves more than a simple modulation of the equilibrium between resting and desensitized states.


Key words: Nicotinic cholinergic, Ion channel regulation, Optical spectroscopy (fluorescence, DC, etc.), Receptor binding studies





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics